Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ken Namikawa
Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Related publications
HER2 Loss in HER2-positive Gastric or Gastroesophageal Cancer After Trastuzumab Therapy: Implication for Further Clinical Research
International Journal of Cancer
Cancer Research
Oncology
A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Multicenter Phase II Study of Trastuzumab Plus S-1 Alone in Elderly Patients With HER2-positive Advanced Gastric Cancer (JACCRO GC-06)
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Prognostic Implications of HER2 Heterogeneity in Gastric Cancer
Oncotarget
Oncology
NT-proBNP Correlates With LVEF Decline in HER2-positive Breast Cancer Patients Treated With Trastuzumab
Cardio-Oncology
The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer
Scientific Reports
Multidisciplinary
O1-20-2a Randomized Phase II Study to Assess Trastuzumab Beyond Progression in HER2-positive Advanced Gastric Cancer: WJOG7112G
Annals of Oncology
Medicine
Oncology
Hematology
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine
Medicine
